PortfoliosLab logoPortfoliosLab logo
PCTY vs. NBIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PCTY vs. NBIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Paylocity Holding Corporation (PCTY) and Neurocrine Biosciences, Inc. (NBIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PCTY achieves a -28.63% return, which is significantly lower than NBIX's 12.64% return. Over the past 10 years, PCTY has underperformed NBIX with an annualized return of 10.51%, while NBIX has yielded a comparatively higher 13.16% annualized return.


PCTY

1D
0.56%
1M
4.42%
YTD
-28.63%
6M
-27.87%
1Y
-40.19%
3Y*
-17.24%
5Y*
-9.20%
10Y*
10.51%

NBIX

1D
-1.81%
1M
-0.97%
YTD
12.64%
6M
4.55%
1Y
27.80%
3Y*
18.64%
5Y*
10.13%
10Y*
13.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PCTY vs. NBIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PCTY
Paylocity Holding Corporation
-28.63%-23.55%21.00%-15.14%-17.74%14.69%70.43%100.66%27.67%57.15%
NBIX
Neurocrine Biosciences, Inc.
12.64%3.90%3.60%10.31%40.24%-11.14%-10.83%50.53%-7.96%100.49%

Correlation

The correlation between PCTY and NBIX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Mar 19, 2014

0.28

Over the past year, the correlation between PCTY and NBIX has dropped to 0.07 - well below their long-term average of 0.28, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

PCTY:

$5.99B

NBIX:

$16.52B

EPS

PCTY:

$4.64

NBIX:

$6.53

PE Ratio

PCTY:

23.46

NBIX:

24.46

PEG Ratio

PCTY:

0.69

NBIX:

0.48

PS Ratio

PCTY:

3.50

NBIX:

5.27

PB Ratio

PCTY:

5.07

NBIX:

4.85

Total Revenue (TTM)

PCTY:

$1.73B

NBIX:

$3.10B

Gross Profit (TTM)

PCTY:

$1.20B

NBIX:

$3.05B

EBITDA (TTM)

PCTY:

$394.81M

NBIX:

$881.20M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PCTY vs. NBIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCTY
PCTY Risk / Return Rank: 77
Overall Rank
PCTY Sharpe Ratio Rank: 44
Sharpe Ratio Rank
PCTY Sortino Ratio Rank: 55
Sortino Ratio Rank
PCTY Omega Ratio Rank: 77
Omega Ratio Rank
PCTY Calmar Ratio Rank: 1212
Calmar Ratio Rank
PCTY Martin Ratio Rank: 1010
Martin Ratio Rank

NBIX
NBIX Risk / Return Rank: 6868
Overall Rank
NBIX Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
NBIX Sortino Ratio Rank: 6565
Sortino Ratio Rank
NBIX Omega Ratio Rank: 6666
Omega Ratio Rank
NBIX Calmar Ratio Rank: 6868
Calmar Ratio Rank
NBIX Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCTY vs. NBIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Paylocity Holding Corporation (PCTY) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PCTYNBIXDifference
Sharpe ratioReturn per unit of total volatility

-1.97

Sortino ratioReturn per unit of downside risk

-2.97

Omega ratioGain probability vs. loss probability

0.81

1.19

-0.37

Calmar ratioReturn relative to maximum drawdown

-0.81

1.34

-2.14

Martin ratioReturn relative to average drawdown

-1.38

2.94

-4.32

PCTY vs. NBIX - Sharpe Ratio Comparison

The current PCTY Sharpe Ratio is -1.08, which is lower than the NBIX Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of PCTY and NBIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PCTY vs. NBIX - Drawdown Comparison

The maximum PCTY drawdown since its inception was -68.90%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for PCTY and NBIX.


Loading charts...

Drawdown Indicators


PCTYNBIXDifference

Max Drawdown

Largest peak-to-trough decline

-68.90%

-97.21%

+28.31%

Max Drawdown (1Y)

Largest decline over 1 year

-50.04%

-20.90%

-29.14%

Max Drawdown (3Y)

Largest decline over 3 years

-58.08%

-42.89%

-15.19%

Max Drawdown (5Y)

Largest decline over 5 years

-68.90%

-42.89%

-26.01%

Max Drawdown (10Y)

Largest decline over 10 years

-68.90%

-46.39%

-22.51%

Current Drawdown

Current decline from peak

-64.40%

-4.54%

-59.86%

Average Drawdown

Average peak-to-trough decline

-23.48%

-43.84%

+20.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.16%

9.49%

+19.67%

Volatility

PCTY vs. NBIX - Volatility Comparison

Paylocity Holding Corporation (PCTY) has a higher volatility of 12.71% compared to Neurocrine Biosciences, Inc. (NBIX) at 9.63%. This indicates that PCTY's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PCTYNBIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.71%

9.63%

+3.08%

Volatility (6M)

Calculated over the trailing 6-month period

31.99%

23.91%

+8.08%

Volatility (1Y)

Calculated over the trailing 1-year period

37.29%

31.38%

+5.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.69%

32.73%

+7.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.76%

39.13%

+2.63%

Dividends

PCTY vs. NBIX - Dividend Comparison

Neither PCTY nor NBIX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PCTY vs. NBIX - Financials Comparison

This section allows you to compare key financial metrics between Paylocity Holding Corporation and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00M20222023202420252026
502.29M
814.50M
(PCTY) Total Revenue
(NBIX) Total Revenue
Values in USD except per share items

PCTY vs. NBIX - Profitability Comparison

The chart below illustrates the profitability comparison between Paylocity Holding Corporation and Neurocrine Biosciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20222023202420252026
72.3%
98.3%
Portfolio components
PCTY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Paylocity Holding Corporation reported a gross profit of 363.19M and revenue of 502.29M. Therefore, the gross margin over that period was 72.3%.

NBIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.

PCTY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Paylocity Holding Corporation reported an operating income of 156.76M and revenue of 502.29M, resulting in an operating margin of 31.2%.

NBIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.

PCTY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Paylocity Holding Corporation reported a net income of 111.25M and revenue of 502.29M, resulting in a net margin of 22.2%.

NBIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.


Frequently Asked Questions


PCTY and NBIX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PCTY has higher volatility (12.71%) compared to NBIX (9.63%). In terms of maximum drawdown, PCTY dropped -68.90% vs NBIX's -97.21%.

NBIX currently has the higher Sharpe Ratio (0.89 vs -1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PCTY and NBIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer